Phentermine HCL Capsules
Failed Impurities/Degradation Specifications: out-of-specification results obtained for individual unknown impurities found at 30 month Room Temperature Retained Sample stability test.
14,806 recalls, newest first
Failed Impurities/Degradation Specifications: out-of-specification results obtained for individual unknown impurities found at 30 month Room Temperature Retained Sample stability test.
Defective Delivery System: the dropper measurement markings may be reversed, shifted or missing.
Microbial contamination of Non-sterile Products; presence of yeast and potential B. cepacia contamination
Microbial contamination of Non-sterile Products; presence of yeast and potential B. cepacia contamination
Microbial contamination of Non-sterile Products; presence of yeast and potential B. cepacia contamination
Microbial contamination of Non-sterile Products; presence of yeast and potential B. cepacia contamination
Microbial contamination of Non-sterile Products; presence of yeast and potential B. cepacia contamination
Failed Moisture Limits: out of specification test results for water content obtained during stability testing.
Marketed Without An Approved NDA/ANDA: FDA analysis found the product to contain undeclared sildenafil and tadalafil and undeclared milk. The presence of sildenafil and tadalafil makes AMPT Natural Herbal Coffee an unapproved drug for which safety and efficacy have not been established and, therefore, subject to recall. Additionally, this product has been found to contain undeclared milk, milk is recognized as one of the foods reported to have caused deaths due to anaphylactic shock in persons with underlying hypersensitivities.
Failed Tablet/Capsule Specification: out of specification for tablet weight.
Presence of Particulate Matter; stainless steel
Presence of Particulate Matter: Silicone oil
Presence of Particulate Matter: Silicone oil
Presence of Particulate Matter: Silicone oil
Failed Impurities/Degradation Specifications: high out of specification results for related compound D.
Failed Tablet/Capsule Specification; out of specification for tablet weight
Marketed Without An Approved NDA/ANDA: Tainted Product Marketed As a Dietary Supplements: products found to be tainted with sibutramine making these unapproved drugs.
Marketed Without An Approved NDA/ANDA: Tainted Product Marketed As a Dietary Supplements: products found to be tainted with sibutramine making these unapproved drugs.
Marketed without an Approved NDA/ANDA;FDA analysis found product to be tainted with sildendafil and tadalafil
Failed Impurities/Degradation Specification: single unknown impurity OOS 0.33% (Limit:NMT 0.20%W/W) at the three month stability point.
Failed impurities/degradation specifications: Out of specification for a related compound C.
Marketed without an approved NDA/ANDA: presence of undeclared desmethyl carbodenafil and undeclared milk.
Subpotent Drug: products are labeled as having SPF 10 protection; however, this claim cannot be 100% guaranteed.
Subpotent Drug: products are labeled as having SPF 10 protection; however, this claim cannot be 100% guaranteed.
Subpotent Drug: products are labeled as having SPF 10 protection; however, this claim cannot be 100% guaranteed.